Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Submitted by
admin
on April 24, 2013 - 9:34am
Source:
Yahoo/AP
News Tags:
Merck
lambrolizumab
FDA
MK-3475
melanoma
Headline:
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Do Not Allow Advertisers to Use My Personal information
